InflaRx N.V.
For the period ended Nov 3, 2026. Filed Nov 3, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Nov 3, 2026 · Filed Nov 3, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99.1 · Share-based payment expense recognized
Share-based payment expense recognized
For the nine months ended September 30, 2026, the Company recognized €1.9 million of share-based payment expense in the statements of operations and comprehensive loss.
For the nine months ended September 30, 2025, the Company recognized €4.2 million of share-based payment expense in the statements of operations and comprehensive loss, including €356 thousand for the extension of certain option terms from eight years to ten years.
None of the share-based payment awards were dilutive in determining earnings per share due to the Group’s loss position.
For the three months ended September 30, 2026, the Company recognized €0.4 million (2025: €0.6 million) of share-based payment expense in the statements of operations and comprehensive loss.
c)
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.